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Affinity-purified  polyclonal  antibodies,  raised 
against  two  synthetic  peptides  corresponding  to  the R 
domain and  the C terminus of the human  cystic fibrosis 
transmembrane  conductance  regulator (CFTR), were 
used to  characterize  and localize the  protein  in  human 
epithelial cells. Employing an immunoblotting tech- 
nique that  ensures  efficient  detection of large  hydro- 
phobic  proteins, both antibodies  recognized an  approx- 
imately  180-kDa  protein  in  cell  lysates  and  isolated 
membranes of airway  epithelial cells  from  normal and 
cystic  fibrosis (CF) patients  and of T84 colon carci- 
noma cells. Reactivity  with  the a n t i 4  terminus  anti- 
body, but not with  the  anti-R domain  antibody,  was 
eliminated by limited carboxypeptidase Y digestion. 
When normal CFTR cDNA was  overexpressed  via a 
retroviral  vector  in  CF or normal airway epithelial 
cells or in mouse fibroblasts,  the  protein produced  had 
an apparent molecular  mass of about 180 kDa. The 
CFTR  expressed  in  insect (Sf9) cells  by a baculovirus 
vector  had a molecular  mass of about 140 kDa,  prob- 
ably  representing a nonglycosylated  form. The CFTR 
in epithelial  cells  appears  to  exist  in  several  forms. N -  
glycosidase treatment of T84 cell  membranes  reduces 
the  apparent molecular  mass of the major  CFTR  band 
from 180 kDa  to  140  kDa,  but a fraction of the T84 
cell CFTR could not be deglycosylated, and  the CFTR 
in  airway epithelial  cell  membranes could not  be  degly- 
cosylated either. Moreover, wheat  germ  agglutinin  ab- 
sorbs  the  majority of the CFTR from  detergent-solu- 
bilized T84 cell  membranes  but  not  from  airway cell 
membranes. The CFTR in  all  epithelial cell  types  was 
found to  be  an  integral  membrane  protein  not solubi- 
lized  by  high salt or lithium  diiodosalicylate treatment. 
Sucrose  density  gradient  fractionation of crude mem- 
branes  prepared  from  the  airway  epithelial ce ls, pre- 
viously  surface-labeled  by  enzymatic  galactosidation, 
showed a plasma  membrane  localization  for  both  the 
normal CFTR and  the CFTR carrying  the Phe608 dele- 
tion (AF 508). The CFTR in all cases co-localized with 
the Na+,K+-ATPase and  the  plasma  membrane calcium 
ATPase,  while  the endoplasmic  reticulum  calcium 
ATPase  and  mitochondrial  membrane  markers  were 
enriched at  higher  sucrose densities.  Thus, the CFTR 
appears  to be localized in  the  plasma  membrane  both 
in normal  and AF 508 CF  epithelial cells. 
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The gene containing the mutations responsible for the 
development of the  lethal genetic disease, cystic fibrosis (CF),’ 
has been cloned (1-3), and  the hypothetical protein  product 
has been named the Cystic Fibrosis Transmembrane Con- 
ductance Regulator (CFTR) (2). Based on hydropathy  analy- 
sis and homologies with specific domains of other proteins, 
the gene product has been predicted to  contain 12 membrane- 
spanning regions, two nucleotide binding domains, a large 
regulatory (R) domain with numerous sites for phosphoryla- 
tion by protein kinases, and two sites for N-linked glycosyl- 
ation  in  an extracellular segment between the seventh and 
eighth proposed membrane-spanning helices (2). In most CF 
cases, the mutation responsible for the disease, which prob- 
ably stems from a defect in CAMP-dependent regulation of 
epithelial chloride channels (4-9), has been shown to be a 
deletion of the phenylalanine residue at  position 508 (AF 508) 
(3). This information  prompted the suggestion that  the nor- 
mal CFTR is a plasma membrane-localized nucleotide binding 
protein, which either regulates or forms protein kinase A- 
dependent chloride channels (2, 10, 11). 
Recent  reports have shown that  the expression of a normal 
CFTR  in AF 508 mutant cells corrects the abnormal chloride 
channel behavior (12-15). Moreover, by expressing the  CFTR 
in insect Sf9 cells, the appearance of CAMP-dependent, pro- 
tein kinase A-regulated chloride channels was demonstrated 
(16). Regarding the pathological effect of the PheSo8 deletion, 
one  report  (17)  indicated that  the AF 508 CFTR expressed in 
heterologous cells had a smaller apparent molecular mass 
than  the normal  protein, and  the suggestion was made that 
the  mutant protein  may not be folded and  then glycosylated 
correctly, resulting  in  a  failure to reach the plasma membrane 
to form or regulate chloride channels. However, no evidence 
was provided for the  maturation  and  the localization of the 
endogenous CFTR protein. 
In spite of the rapid progress in  the xpression of the normal 
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bromo-4-chloro-3-indolyl phosphate p-toluidine salt; CHAPS, 3-[(3- 
cholamidopropyl)-dimethylammonio]-l-propanesulfonate; CFTl 
cells, human papilloma virus E6 and E7 gene transformed human CF 
tracheal epithelial cells (homozygous for AF 508 mutation);  CF-T43 
cells, SV 40T transformed  human  CF nasal epithelial cells (homozy- 
gous for AF 508 mutation); CFTR, cystic fibrosis transmembrane 
conductance regulator; EGTA, [ethylenebis(oxyethylenenitrilo)]tet- 
raacetic acid; HBE cells, human papilloma virus E6 and E7 gene 
transformed normal human  tracheal epithelial cells; KLH, keyhole 
limpet hemocyanin; NBT, nitro blue tetrazolium chloride; PMCA, 
plasma membrane calcium ATPase; PMSF, phenylmethylsulfonyl 
fluoride; PVDF, polyvinylidene difluoride; SDS-PAGE, sodium do- 
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CFTR and  the functional  evaluation of this expression, rela- 
tively few data  are available concerning the biochemical na- 
ture of the CFTR in normal and CF epithelial cells. The 
reports which have provided biochemical information  about 
the CFTR (16, 17) have employed in  vitro expression systems 
and/or  the high CFTR-expressor T84 colon carcinoma cell 
line. However, no  data  are  currently available regarding the 
presence, glycosylation, and membrane localization of the 
normal and AF 508 CFTR in airway epithelial cells, where 
abnormal CFTR function  results  in the  lethal consequences 
of the CF disease. 
In the present report, using antibodies specific for two 
different regions of the CFTR and  an immunodetection tech- 
nique with high efficiency and sensitivity, we describe a 
variety of biochemical features of this protein  in normal and 
CF (AF 508 homozygote) airway epithelial cells as well as T84 
colon carcinoma cells which are of epithelial origin. We also 
compare the characteristics of these  proteins to those over- 
expressed via viral vectors in human airway epithelial cells, 
mouse NIH 3T3 fibroblasts, and insect Sf9 cells. In addition 
to establishing several fundamental properties of the CFTR 
in normal, CF, and overexpressing cell systems, these studies 
may provide useful tools for future studies of the  structure, 
localization, and function of this newly  recognized protein so 
essential for normal epithelial cell function. 
EXPERIMENTAL  PROCEDURES 
Reagents-N-Glycosidase F from Flavobacterium meningosepti- 
cum, recombinant endoglycosidase H, 0-glycosidase from Diplococcus 
pneumoniae, and neuraminidase from Vibrio  cholerae  were obtained 
from Boehringer Mannheim. [3H]UDP galactose, prestained molec- 
ular mass standards, and enhanced chemiluminescence Western blot- 
ting reagents were from Amersham. Carboxypeptidase Y ,  lithium 
diiodosalicylate, galactosyltransferase, lectin-agarose beads, NBT, 
BCIP, PMSF, aprotinin, and leupeptin were from Sigma; CHAPS 
and Sulfolink resin were  from Pierce. Synthetic peptides were pre- 
pared in the  Protein Chemistry Laboratory of UNCCH-NIEHS. 
Antibodes-Polyclonal antibodies against synthetic peptides de- 
duced from the CFTR gene sequence (2) as likely to be antigenic (18) 
were raised in rabbits. Antibodies “ R  (K770 and K50) were raised 
against  a KLH-conjugate of the peptide identical with residues 776- 
795 (SVNQGQNIHRKTTASTRKVS), while antibodies “C” (K858 
and K82) were raised against  a  KLH-peptide identical with residues 
1458-1480 (CKSKPQIAALKEETEEEVQDTRL). The C terminus 
peptide, containing a cysteine at  its N terminus, was directly coupled 
to KLH by the sulfhydryl reactive reagent, m-maleimidobenzy1-N- 
hydroxysuccinimide ester, while the R domain peptide was synthe- 
sized with a cysteine added to its N terminus and then similarly 
coupled to KLH. Rabbits were immunized with 500  pg  of the peptide- 
KLH complexes in complete Freund’s adjuvant, by intradermal injec- 
tions. One month later,  intradermal injections were repeated using 
200  pg  of peptide in Freund’s incomplete adjuvant. Subsequently, the 
rabbits were boosted with monthly intraperitoneal injections of the 
peptide-KLH complexes adsorbed to aluminum hydroxide. Ten days 
after each boost, rabbits were bled, and  the sera were isolated. Sera 
(1:lOO dilutions) were screened for the presence of anti-peptide anti- 
bodies by incubation with 2 fig of peptide immobilized on nitrocellu- 
lose. Bound antibodies were detected subsequently by incubation with 
alkaline phosphatase-conjugated anti-rabbit IgG followed by color 
development with NBT + BCIP (see below). The antibodies were 
affinity-purified by using the relevant peptides covalently linked to 
Sulfolink resin. Bound antibodies were eluted with 0.1 M glycine- 
HCl,  pH 2.8, and were immediately neutralized by the addition of 1 
M Tris base. 
A monoclonal antibody specific for the human  erythrocyte mem- 
brane calcium ATPase (PMCA), 5F10, was kindly provided by Dr. J. 
T. Penniston. A monoclonal antibody raised against the dog cardiac 
sarcoendoplasmic reticulum calcium ATPase  (SERCA), IId8, was a 
gift of Dr. Kevin Campbell. A polyclonal antibody raised against the 
bovine heart inner mitochondrial membrane Complex 111 was kindly 
provided by Dr. C. Hackenbrock. A polyclonal antibody against the 
purified CY + @subunits of the dog kidney Na,K-ATPase was generated 
by  Dr.  E. Price. 
Anti-mouse IgG (whole molecule) and anti-rabbit IgG (whole mol- 
ecule) alkaline phosphatase-conjugated F(ab’) fragments, developed 
in sheep, were obtained from Sigma. Peroxidase-conjugated, affinity- 
isolated anti-mouse antibody, developed in goat, was from TAGO, 
Inc. AffiniPure anti-rabbit antibody, developed in goat, peroxidase- 
conjugated, was from Jackson ImmunoResearch Laboratories. 
Cell Lines and Membrane Preparatwn-Human airway epithelial 
cell lines used in this study were: Beas cells, a line of SV40 large T 
antigen immortalized normal human tracheal epithelial cells (19); 
CF-T43 cells, a line of similarly immortalized nasal epithelial cells 
from a homozygous AF 508 CF patient, which retain the CF genotype 
and phenotype (20); HBE cells, normal human bronchial epithelial 
cells immortalized by human papilloma virus E6 and E7 genes; and 
CFTl cells, human  tracheal epithelial cells from a homozygous AF 
508 CF  patient, immortalized by human papilloma virus E6 and E7 
genes. T84 cells, derived from a  human colon cancer, and HeLa cells, 
of human cervical cancer origin, were obtained from the American 
Type Tissue Culture Collection, Rockville, MD. The special culturing 
conditions for the airway cells are described in Refs. 19 and 20. 
Cell extracts and crude membrane fractions were prepared from 
the various cultured cells as follows: confluent cell cultures were 
washed in phosphate-buffered saline and  the cells were scraped into 
Tris mannitol buffer (50 mM Tris,  pH 7.0, with HCl, containing 300 
mM mannitol and 0.5 mM PMSF). When the proteins of whole cells 
were to be assayed, the cell suspensions were precipitated with tri- 
chloroacetic acid (4% w/v final  concentration) and centrifuged for 5 
min at  5,000 X g,  and  the pellet was dissolved in SDS-PAGE disag- 
gregation buffer (see below). For membrane preparations, the cells 
were  lysed and homogenized using a glass-Teflon tissue homogenizer 
in TMEP (50 mM Tris,  pH 7.0, with HC1, containing 50 mM mannitol, 
2 mM EGTA, 10 pg/ml leupeptin, 8 pg/ml aprotinin, 0.5 mM PMSF, 
and 2 mM 8-mercaptoethanol), and  the undisrupted cells and nuclear 
debris were removed by centrifugation at 500 X g for 10 min. The 
supernatant fluid was then centrifuged for 60 min at 100,000 X g, and 
the pellet containing the membranes was resuspended in TMEP  at a 
protein  concentration of  5-10 mg/ml.  All procedures were carried out 
at 4 “C, and  the membranes were stored at -70 “C.  Human red cell 
membrane vesicles and lymphoblast (Jurkat) membranes were pre- 
pared as described previously (21,22). 
SDS-PAGE and Immunoblotting-Membrane suspensions were 
either directly mixed with disaggregation buffer (50 mM Tris,  pH 6.8, 
with H3P04, containing 2% SDS (w/v), 15% glycerol (w/v), 2% @- 
mercaptoethanol (v/v), 1 mM EDTA, and 0.02% (w/v) bromphenol 
blue) or precipitated with trichloroacetic acid (4% (w/v) final concen- 
tration), centrifuged for 5 min at 5,000 X g, and  then suspended in 
the disaggregation buffer. Samples were disaggregated at room tem- 
perature for 20 min at a  protein  concentration of  1-3 mg/ml. Electro- 
phoresis of the samples was usually carried out using Bio-Rad Mini- 
Protean ready gels (4-15% acrylamide gradient, 0.375 M Tris-HC1, 
pH SA), in  a  Mini-Protean cell. The maximum amount of membrane 
protein which could be run  in  these gels with good resolution was 
about 50 pglwell. For increased resolution of the high molecular mass 
proteins or for loading greater amounts of membrane proteins, elec- 
trophoresis was carried out  in Laemmli-type gels (15- X 15-cm 6% 
acrylamide resolving gel with 5% acrylamide stacking gel) in  a Hoefer 
electrophoresis cell. The running buffer contained 25 mM Tris glycine, 
pH 8.3, and 0.2% (w/v) SDS. In the Mini-Protean cells, gels  were run 
for 60 min at  110 V, the large gels were run for 4 h at 100 V. 
Electroblotting of the proteins was carried out in a Tris buffer 
containing  a high concentration of glycine and no methanol (0.7 M 
glycine, 25 mM Tris, pH 7.7), which provided an efficient transfer of 
large hydrophobic proteins  as described in Ref.  23, in Bio-Rad Trans- 
Blot cells (35 V, 12 h, 15 “C) or in  Mini-Trans-Blot cells (60 V, 1.5 
h, with cooling unit). In order to obtain efficient binding of the 
proteins, PVDF membranes (Bio-Rad, 0.2-p pore size) were used. 
When nitrocellulose membranes were  used as  in Ref.  23, most of the 
proteins migrated through the membrane. For molecular mass esti- 
mation, Amersham Rainbow prestained standards and Bio-Rad high 
molecular mass standards were  used. 
For immunodetection of the proteins, PVDF membranes with the 
blotted proteins were incubated in TBS-Tween solution (200 mM 
NaCl and 0.1% (v/v) Tween 20 in 50 mM Tris,  pH 7.4, with HCl) 
containing 5% (w/v) Carnation nonfat dry milk, for 60 min at room 
temperature. Polyclonal anti-CFTR antibodies were diluted lOO-fold, 
while other polyclonal and monoclonal antibodies were diluted 500- 
fold in the TBS-Tween-milk buffer and incubated with the blots for 
60 min. The blots were then washed twice for 15 min in TBS-Tween 
solution and incubated with the appropriate second antibody solu- 
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tions (peroxidase-conjugated antibodies diluted 20,000-fold, alkaline 
phosphatase-conjugated antibodies diluted 750-fold) for 60 min. The 
blots were then washed three times (15 min each) in TBS-Tween 
solution. The alkaline phosphatase-labeled blots were developed in 
color reaction buffer (100 mM NaCl and 5 mM MgC1, in 100 mM Tris, 
pH 9.5, with HCl),  containing 0.3 mg/ml NBT  and 0.15 mg/ml BCIP 
(24). Peroxidase-labeled blots were  developed by the enhanced chemi- 
luminescence method, using the Amersham kit. Protein  staining  on 
the PVDF blots was carried out by immersing the membrane in 
methanol for 10 s and then staining for 3 min in a mixture of 
methano1:acetic acidwater (5:1:5) containing 0.2% (w/v) Coomassie 
Brilliant Blue  R-250. Destaining was achieved by shaking  in several 
changes of the above methanol/acetic acid/water mixture over a 
period of 20 min. Quantitative  densitometry of the x-ray films from 
the luminograms of the alkaline phosphatase reaction-stained bands 
on the PVDF membranes was performed with a Hoefer model GS- 
300 scanning densitometer interfaced with an Apple I1 computer. A 
density scan program was used to integrate the relevant peak areas. 
Carboxypeptidase and Glycosidase Treatment of Isolated Mem- 
branes-Carboxypeptidase Y digestion of the isolated membranes 
was carried out by incubating the crude membrane suspensions (1.5 
mg of membrane protein/ml) in 25 mM Tris, pH 7.0, with HCl, 
containing 100 mM KC1 and 2 mM EDTA, with 75 units/ml of 
carboxypeptidase Y at  room temperature for the indicated time 
periods. In some experiments, the incubation solutions were supple- 
mented with 0.5% (v/v) Triton X-100. The reaction was terminated, 
and  the membranes were collected by trichloroacetic acid precipita- 
tion (4% (w/v) final concentration) and  then dissolved in  SDS-PAGE 
disaggregation buffer. 
N-Glycosidase digestion of the cell membranes was carried out as 
described (16). In brief, crude membranes were disaggregated for 15 
min at room temperature  in 2% (w/v) SDS, and  the mixture was then 
diluted 10-fold with a solution containing 25 mM EDTA and 1% (v/ 
v) Triton X-100 and incubated with 2 units of N-glycosidase/300 pg 
of membrane protein at 37 “C for 15 h. The membranes were then 
precipitated by ice-cold ethanol, and  the pellet was dried in vacuo 
and dissolved in SDS-PAGE disaggregation buffer. 0-Glycosidase 
and neuraminidase treatment of the membranes were carried out 
under similar conditions. In certain experiments, membranes sus- 
pended in SDS-free or EDTA-free buffers were used. 
Expression of the CFTR in Airway, NIH 3T3, and Sf9 Cells-The 
LCFSN retrovirus vector was constructed by insertion of a 4.5- 
kilobase pair AvaI-SstI fragment containing the normal CFTR cDNA 
(15)  into the EcoRI site of the plasmid pLXSN (26). All ends were 
made blunt using the large fragment of DNA polymerase I. A stable 
retrovirus packaging cell line producing LCFSN was derived from the 
amphotropic cell line PA317 (American Type Tissue Culture Collec- 
tion, Rockville, MD), essentially as described previously (26). CFTl 
and HBE airway epithelial cells or NIH  3T3 fibroblasts were infected 
with LCFSN in the presence of 8 pg/ml Polybrene for 2 h. Infected 
cells were selected in the presence of 150 pg/ml (CFT1  and  HBE) or 
250  pg/ml (NIH 3T3) G418.  Mock infection of the cells was carried 
out with a similar vector containing the IL-2 receptor cDNA. 
In order to express the CFTR in Sf9 cells, site-directed mutagenesis 
was used to introduce NotI restriction endonuclease sites at position 
89 and 4594 in the CFTR cDNA. The engineered cDNA was se- 
quenced in its  entirety to verify the absence of any additional muta- 
tions. This analysis detected one nucleotide difference between the 
mutagenized cDNA and  the reported sequence (2). This is  a  C  instead 
of an A at position 1990, identical with the sequence difference 
reported by Gregory et al. (13). The full length cDNA was cloned into 
the NotI  site of the baculovims transfer vector pVL  1392 (In Vitro- 
gen). Recombinant virus containing  CFTR was generated according 
to established procedures (27). Three independent occlusion negative 
plaques were isolated and subjected to a second round of plaque 
purification. When the recombinant viral preparation was used to 
infect Sf9 cells, similar levels of CFTR expression were observed for 
each of the three samples cultured for 4 days. Cells infected with one 
of the viral stocks were further characterized as described under 
“Results.” 
Binding of Solubilized Glycoproteins to Lectin Agarose-Crude 
membranes were  dissolved in solubilization (S) buffer, containing 2% 
(w/v) CHAPS, 1% (v/v) Triton X-100, 0.5 mM PMSF, and 2 mM p- 
mercaptoethanol in 25 mM Tris,  pH 7.0, with HC1, a t  a  final concen- 
tration of about 1 mg  of membrane protein/ml. The suspension was 
incubated for 15 min at  4 “C  and  then diluted with 10 volumes of the 
same buffer without detergents. The solution was then centrifuged 
for 10 min at 1,000 X g, and  the  supernatant fluid was  used for lectin 
binding studies. Lectin agarose beads, preincubated and washed with 
buffer 0.1 X S (containing the same ingradients as buffer S but only 
0.2% (w/v) CHAPS and 0.1% (v/v) Triton X-100) in a final packed 
volume of  0.2 ml, were  mixed with 0.8  ml of the 1000 X g  supernatant 
fluid. After 2  h of incubation (4 “C, with gentle shaking), the lectin 
beads were sedimented by centrifugation for 1 min at  200 X g, and 
the  supernatant fluid was collected and analyzed for the presence of 
CFTR. After three washes of the beads with 5 ml  of buffer 0.1 X S, 
the bound glycoproteins were eluted by incubating the beads for 20 
min with 1 ml of buffer 0.1 X S, containing  a 0.5 M concentration of 
the appropriate sugar. The mixture was centrifuged again for 1 min 
at 200 X g, and  the proteins in the  supernatant fluid were precipitated 
by adjusting the solutions to 4% (w/v) trichloroacetic acid. Protein 
precipitation was facilitated by the addition of 100 pg/ml (final 
concentration) bovine serum albumin. The mixture was centrifuged 
for 5 min at  5,000 X g, and  the pellet was  dissolved in disaggregation 
buffer for SDS-PAGE analysis. The  pH of the samples was neutral- 
ized by the addition of small amounts of Tris base. 
Surface Labeling of Cells  with [3H]UDP-galacto~e-Labeling of  cell 
surface glycoproteins by tritiated galactose was carried out according 
to  the method described in Ref. 25. In brief, approximately 10’ airway 
cells or 5 X 10’ T84 cells, collected as described above, were resus- 
pended in  5 ml  of a buffer containing 160 mM NaC1,25 mM Tris, pH 
7.0, with HCl, 5 mM MnC12,  0.5 units of galactosyltransferase, and  5 
pCi of UDP-[3H]galacto~e and incubated at 4 “C for 40 min. The 
labeled cells were then washed with Tris mannitol buffer, and mem- 
branes were prepared as described above. 
Sucrose Density Gradient Separation of Membranes-Crude  mem- 
branes were resuspended in Tris KC1 buffer (50 mM Tris, pH 7.0, 
with HCl, containing 0.1 M KC1, 0.5 mM €”SF, 2 mM P-mercapto- 
ethanol) a t  a protein concentration of about 0.5 mg/ml, and 2-ml 
aliquots were layered on top of a discontinuous sucrose gradient 
consisting of 2-ml aliquots of 50%, 45%, 35%, and 25% (w/v) sucrose 
in Tris KC1 buffer in a 12-ml centrifuge tube. The gradients were 
centrifuged in  a Beckman SW 40 Ti rotor (150,000 X g average) at 
4 “C for 3 h, and  the  supernatant fluids and  the membrane layers at 
the  top of each sucrose solution (0.6 ml) were collected and assayed 
for protein content and tritium content when appropriate. Addi- 
tionally, the proteins  in 0.5-ml aliquots of the collected samples were 
mixed with 100 pg of bovine serum albumin (final concentration), 
precipitated with trichloroacetic acid (4%  (w/v)) final concentration, 
and  the precipitates were collected by centrifugation. The trichloro- 
acetic acid pellets were then dissolved in the amounts of disaggrega- 
tion buffer necessary to obtain equal membrane protein concentra- 
tions, and the samples were analyzed by SDS-PAGE as described 
above. 
Other Methods-Membrane protein concentrations were deter- 
mined by a modified Lowry method (28). 3H measurements were 
performed in PG 2:l (29) scintillation fluid in a Packard Tri-Carb 
1500 liquid scintillation  counter. 
RESULTS 
Fig. 1 shows Western  blots of several whole epithelial cell 
and membrane  preparations  immunostained by two different 
polyclonal antibodies (K770 and K858) generated against 
polypeptide regions of the R domain (anti-CFTR-R)  and  the 
C terminus  (anti-CFTR-C) of the CFTR, and affinity-purified 
by binding to  the respective synthetic peptides as described 
under  “Experimental Procedures.” In  the trichloroacetic acid- 
precipitated, SDS-solubilized epithelial cells (panel A )  or 
crude membrane preparations thereof (panels B and C ) ,  both 
antibodies recognized several proteins including an approxi- 
mately 180-kDa protein, which, as will be elaborated upon 
below, corresponds to  the CFTR. This recognition was absent 
when the antibodies were preincubated with the relevant 
peptides (panels A and C,  lane 5). Although shown only for 
the T84 cells, immunostaining of all of the bands  in the  other 
cells was likewise eliminated by preincubation of the antibod- 
ies with their specific peptides. 
Consistent  with the results shown in Fig. 1, in  experiments 
carried out with more than 10 different cell and membrane 
preparations, the 180-kDa bands were present with about 
equal densities in  both normal (Beas, HBE)  and  CF (AF 508 
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FIG. 1. Recognition of epithelial cell proteins by the anti-CFTR  antibodies. Intact cells ( A )  or crude 
membrane preparations (B,C)  precipitated with trichloroacetic acid and dissolved in SDS-PAGE disaggregation 
buffer were electrophoresed in 4-15% acrylamide gradient SDS-PAGE gels and blotted onto PVDF membranes as 
described under  “Experimental Procedures.” The binding of anti-CFTR R domain (K770, panels A and B )  and of 
anti-CFTR C  terminus (K858, panel C )  anti-peptide antibodies was detected by a peroxidase-conjugated second 
antibody using the chemiluminescence method. Samples  containing 50 pg  of protein were deposited in each well. 
Lanes 1, Beas cells or membranes; lanes 2, CF-T43 cells or membranes; lanes 3, T84 cells or membranes; lane 4, 
cells from a  primary  culture of airway epithelial cells from a  CF (AF 508 homozygote) patient; lanes 5, T84 cells 
or membranes, immunodetection performed after preincubation of the  anti-CFTR antibodies with the appropriate 
peptides (20 pg/ml) for 2 h. The numbers on the scales or arrows in each figure show M, + 1,000. 
homozygote CF-T43 and CFT1) cells or in their isolated 
membranes. In T84 cells or membranes, the  band appeared 
to be broader and more diffuse (see below), and  the  intensity 
of immunostaining  in the 180-kDa region was always 20-50 
times greater than  in  the airway cells, whether compared on 
the basis of cell number or membrane protein. As demon- 
strated  in Fig. lA, lane 4, the 180-kDa band was also recog- 
nized by the  anti-CFTR antibody  in cells of a  primary  culture 
of an airway tissue sample obtained from a AF 508 CF  patient. 
A similar recognition of the 180-kDa band was observed in 
nasal scrapes of normal individuals and the CF (AF 508 
homozygote) patients  (data  not shown). In HeLa cells and  in 
Jurkat lymphoblast membrane  preparations,  a 180-kDa band 
was also observed, albeit  with less intensity  than  in  the airway 
cells, while no  protein staining by either antibody could be 
detected in isolated human red blood cell membranes (not 
shown). 
Fig. 1 also clearly shows that  the two anti-peptide  antibod- 
ies recognized several higher and lower molecular mass  pro- 
teins  in addition to  the 180-kDa protein. In epithelial cells 
and membranes, the K770 anti-R antibody recognized pro- 
teins at  about 350 kDa, 140 kDa, 105 kDa, and  an intensive 
triplet between 45 and 55 kDa. The  anti-C antibody K858 
recognized bands at  140 kDa, 105 kDa, 65 kDa, and 40 kDa. 
The fact that all of these bands disappeared in  the peptide 
competition experiments (Fig. 1, lanes 5 )  indicates the pres- 
ence of similar epitopes in  these proteins. Two other antibod- 
ies, generated against the R domain and  the C terminus of 
the CFTR (K50 and K82), recognized the same 180- and 140- 
kDa bands and weakly the 105-kDa bands in  all the epithelial 
cell types, while the recognition pattern for the lower molec- 
ular weight bands was different (see below, Fig. 3). Although 
a protein with about the expected molecular mass of the 
CFTR (168,000 + possible glycosylation) is clearly recognized 
by both  types of our anti-CFTR polyclonal antibodies  in the 
epithelial cells and their isolated membranes, the obvious 
presence of several other antibody-reactive  proteins in  these 
cells necessitated a further investigation of the identity of the 
180-kDa band. In order to determine whether or not the 
epitope recognized  by the  anti-C  terminus antibody is indeed 
at  the C terminus of the various proteins,  a limited carboxy- 
peptidase Y digestion of the isolated cell membranes was 
performed, and  the products were analyzed in Western blots. 
Incubations were carried out a t  room temperature with or 
without 0.5% Triton X-100 in the medium. As shown in Fig. 
2, panel B, lane 3, a  5-min carboxypeptidase Y digestion of 
the isolated T84 membranes  in the presence of  0.5% Triton 
X-100 eliminated the recognition of the 180-kDa band, as 
well as the lower molecular mass proteins, by the anti-C 
terminus antibody. In  the absence of detergent, only about  a 
50% decrease in  the  intensity of the 180-kDa immunoreactive 
band was observed, even though the digestion was carried out 
for 60 min (lane 2). The detergent effect suggests that some 
of the antibody-reactive  proteins are present  in sealed vesicles 
with their C terminus inaccessible to  the enzyme. In similar 
experiments with an  anti-R domain  antibody (panel A ) ,  there 
A. CFLa-R B. CFLa-C 
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FIG. 2. Effect of carboxypeptidase Y digestion on the rec- 
ognition of the epithelial cell membrane proteins by the anti- 
CFTR antibodies. T84 cell membranes were treated with carboxy- 
peptidase Y, precipitated with trichloroacetic acid, and dissolved in 
SDS-PAGE disaggregation buffer as described under “Experimental 
Procedures.” Samples were electrophoresed and immunoblotted, and 
the immunostaining was visualized as described in the legend  for  Fig. 
1. Each lane  contained 50 pg  of membrane protein. Panel A, detection 
with anti-CFTR R domain (K770) anti-peptide antibody; panel B, 
detection with anti-CFTR C  terminus (K858) anti-peptide antibody. 
Lanes 1, membranes incubated for 60 min without carboxypeptidase 
Y in the presence of 0.5% Triton X-100; lanes 2, membranes incubated 
for 60 min with carboxypeptidase Y in the absence of 0.5% Triton 
X-100; lanes 3, membranes incubated for 5 min with carboxypeptidase 
Y in the presence of 0.5% Triton X-100. 
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was  no change in the recognition of the immunoreactive bands 
over  a 60-min period, irrespective of the presence or absence 
of detergent. Identical results were obtained with isolated 
membranes of Beas and  CF-T43 airway epithelial cells (data 
not shown). These findings support  the identity of the  CFTR 
with the 180-kDa band recognized by the anti-C terminus 
antibody. 
To  further explore the identity of the 180-kDa protein, we 
examined the expression of the CFTR by introducing its 
cDNA into several host cells via viral vectors. For these 
experiments, the antibody-reactive proteins were separated 
in longer, 6% Laemmli-type gels, which provide a better 
resolution for the 180-kDa region than  the minigels. As shown 
in Fig. 3A, lanes 1, in T84 cells, both  the R domain (K770 
and K50) and  the C terminus (K858) antibodies recognize a 
broad, multiple, and/or fuzzy band between 165- and 185 kDa, 
and a sharp band at  the  top of it (about  185 kDa), slightly 
overlapping the fuzzy band. In  CFTl (AF 508 homozygote) 
airway cells (lanes 2 ) ,  this  latter  sharp  band  and minor bands 
corresponding to  the broad T84 band  are apparent. In all the 
cells, a band at  140 kDa is also recognized by both  the R 
domain and  the C terminus antibodies. A  similar  picture was 
observed in the case of all the airway epithelial cell types 
examined (not shown). 
Retroviral introduction of the normal CFTR into CFTl 
(Fig. 3A, lanes 3 )  airway epithelial cells induced a  dramatic 
increase  in the immunoreactive bands  in  the 180-kDa region, 
including increases in  the intensities of the  sharp upper  band, 
the broad fuzzy band, and  the 140-kDa band. Importantly, 
these increases were seen with  all three  anti-CFTR antibodies. 
Although not shown, similar  results were obtained  with  con- 
trol  and  CFTR cDNA-infected normal (HBE) airway epithe- 
lial cells. Collectively, these data strongly suggest that  the 
immunoreactive bands  in the 180-kDa and 140-kDa regions 
represent various forms of the  CFTR protein. 
Fig. 3B demonstrates expression of the  CFTR  in mouse 
NIH 3T3 fibroblasts and in insect Sf9 cells, again using 
appropriate viral vectors. In  the control (mock-infected) 
mouse NIH  3T3 fibroblasts (lanes I), the  anti-CFTR  anti- 
bodies reported a low level of the 180- and 140-kDa proteins. 
The CFTR expressed in these cells via a retroviral vector 
(lanes 2 )  was clearly recognized as a broad band at  an  apparent 
molecular mass of about 180 kDa by both the  anti-R domain 
and  anti-C  terminus antibodies. When expressed in  the cul- 
tured insect  ovarian Sf9 cells via a baculovirus containing the 
CFTR cDNA (lanes 3) ,  the  CFTR  had  an  apparent molecular 
mass of about 140 kDa, as reported by both antibodies. In  the 
control Sf9 cells, with the small amount of protein applied in 
the electrophoresis wells, no endogenous antibody reactivity 
was detected. The lower molecular mass of the  CFTR in Sf9 
cells presumably results from inefficient glycosylation in this 
system (16, and see below). 
It is important  to note that in the CFTR-overexpressing 
epithelial cells or fibroblasts there was no major change in 
the  amount of another characteristic  membrane  protein, the 
plasma membrane calcium ATPase, and no  significant differ- 
ences could be observed in  the protein pattern of the Coo- 
massie blue-stained blots (not shown). These  latter  data  in- 
dicate that  the CFTR, even when overexpressed, is a  minor 
protein component of the mammalian cell membranes. In 
CFTR-expressing Sf9 cells, a visible, although low intensity 
protein band, at  140 kDa could be detected by Coomassie 
Blue  staining. 
Taken together, all of the above data suggest that the 
approximately 180-kDa proteins recognized in the epithelial 
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FIG. 3. A, expression of the CFTR in human airway epithelial 
cells.Intact cells were precipitated with trichloroacetic acid and dis- 
solved in SDS-PAGE disaggregation buffer. Samples were electro- 
phoresed on 6% acrylamide gels. Immunoblotting and  the immuno- 
staining with anti-CFTR antibodies were carried out  as described in 
the legend for Fig. 1. In each well, 50 pg of protein was deposited. 
Panel I, detection with anti-CFTR R domain (K770) anti-peptide 
antibody; panel II, detection with anti-CFTR R domain (KFjO) anti- 
peptide antibody; panel III, detection with anti-CFTR C terminus 
(K858) anti-peptide antibody. Lanes I ,  T84 cells; lanes 2, CFTl cells; 
lanes 3, CFTl cells infected with a retroviral vector containing the 
normal CFTR cDNA. B, expression of the CFTR in mouse NIH 3T3 
fibroblasts and insect Sf9 cells. Intact cells were precipitated with 
trichloroacetic acid and dissolved in SDS-PAGE disaggregation 
buffer. Samples were electrophoresed and immunoblotted, and the 
immunostaining was visualized as described in the legend  for Fig.  3A. 
Lanes 1 and 2 contained 50 pg  of protein,  and lanes 3 contained 2 pg 
of protein. Panel I, detection with anti-CFTR R domain (K770) anti- 
peptide antibody; panel ZI, detection with anti-CFTR C terminus 
(K858) anti-peptide antibody. Lanes I ,  NIH 3T3 cells; lanes 2, NIH 
3T3 cells infected with the retroviral vector containing the normal 
CFTR cDNA; lanes 3, Sf9 cells infected with a baculovirus vector 
containing the CFTR cDNA and cultured for 4 days. 
represent the CFTR. They also point to a polydispersity of 
the CFTR, probably caused by glycosylation and/or other 
post-translational modifications. 
In  the following experiments we intended to examine the 
nature of the possible glycosylation of the CFTR in the 
epithelial cells. Again using 6% gels for higher resolution, we 
found that, when isolated, detergent-treated T84 membranes 
were incubated  with N-glycosidase, the molecular mass of the 
major, broad CFTR band decreased from about 180 kDa to 
140 kDa (Fig. 4A, lanes 1 and 2 ) .  However, a sharp band  near 
the  top (about 185 kDa),  and  another band, near to  the lower 
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FIG. 4. A,  N-glycosidase digestion of T84 and CFTR-expressing 
Sf9 cell membranes. Detergent-solubilized membranes were treated 
with N-glycosidase as described under  “Experimental Procedures.” 
Samples were electrophoresed and immunoblotted, and  the immuno- 
staining was visualized as described in the legend for panel A. Im- 
munodetection was carried out with anti-CFTR C  terminus antibody, 
K858. Lane 1, T84 cell membranes (50 pg of protein), incubated 
overnight without N-glycosidase; lane 2, T84 cell membranes (50 pg 
of protein) incubated overnight with 2 units of N-glycosidase; lane 3, 
2 pg of protein from Sf9 cells expressing the CFTR, incubated 
overnight without N-glycosidase; lane 4, 2 pg of protein from Sf9 
cells expressing the CFTR, incubated overnight with 2 units of N -  
glycosidase. B, wheat germ agglutinin-agarose absorption of the 
CFTR. T84 cell membranes were treated with the lectin agarose, 
precipitated with trichloroacetic acid and dissolved in SDS-PAGE 
disaggregation buffer as described under  “Experimental Procedures.” 
Samples were electrophoresed and immunoblotted, and  the immuno- 
staining by the  anti-CFTR antibodies was visualized as described in 
the legend for Fig. 1. Immunoblots with anti-PMCA and anti-SERCA 
antibodies were  developed with alkaline phosphatase-conjugated sec- 
ond antibodies. Panel I ,  detection with anti-CFTR C domain (K858) 
antipeptide antibody; panel 11, detection with the anti-PMCA mono- 
clonal antibody; panel 111, detection with the anti-sarcoendoplasmic 
reciculum calcium ATPase (SERCA) monoclonal antibody. Lanes 1, 
50 pg of T84 membrane protein solubilized in 2% (w/v) CHAPS + 
1% (v/v) Triton X-100; lanes 2, 5 pg of WGA-agarose-isolated T84 
membrane proteins plus 50 pg of bovine serum albumin (see “Exper- 
imental Procedures”). 
edge (about 160-165 kDa) of the major CFTR band, were not, 
or only partially, degraded. By using different deglycosylation 
periods up to 72 h,  no further degradation of these bands was 
detected, and, although shown here only for the anti C- 
terminus antibody, K858, the same changes were reported by 
the  anti-R antibodies. The molecular mass of the 14O-kDa, 
deglycosylated CFTR was identical with that seen  in baculo- 
virus CFTR vector-infected Sf9 cells, in which the 140-kDa 
band was unaffected by N-glycosidase digestion (Fig. 4A, lanes 
3 and 4 ) .  In similar  experiments, N-glycosidase had no visible 
effect on the endogenous CFTR of detergent-treated airway 
epithelial  (Beas,  HBE, CF-T43, and  CFT1) cell membranes, 
and  this was true even when the N-glycosidase was supple- 
mented with neuraminidase and/or 0-glycosidase (not 
shown). I t  should be mentioned that if EDTA was not in- 
cluded in the glycosidase incubation medium, a complete loss 
of the CFTR was observed, probably due to  the action of 
endogenous proteinases. 
For  a further characterization of the glycoprotein nature of 
the  CFTR, detergent-dissolved epithelial cell membranes were 
incubated with a  variety of lectin-agarose beads. No signifi- 
cant binding of the CFTR to concanavalin A, pokeweed 
(Phytolacca americana), lentil ( L e n s  culinaris), or Ricinus 
communis RCAso and RCA,zo lectin agarose beads was de- 
tected, while incubation of T84 membranes with wheat germ 
agglutinin (WGA, Triticum uulgaris lectin) agarose, followed 
by removal of the lectin beads resulted in  a significant (60- 
80%) reduction of the  CFTR  in  the  supernatant fluid. Elution 
of the WGA agarose-bound material with a solution of N- 
acetylglucosamine, which specifically binds to this lectin, 
yielded a  solution  with  significant (8-10-fold) enrichment of 
the  CFTR relative to  other membrane  proteins, with a recov- 
ery of about 20-30% (Fig. 4B, I ) .  Moreover, this purification 
procedure resulted in  the loss of most of the lower molecular 
mass anti-CFTR (K858) antibody-binding proteins. The non- 
glycosylated plasma  membrane calcium ATPase  (PMCA) and 
sarcoendoplasmic reticulum calcium ATPase (SERCA) were 
not detected  in the WGA-agarose eluted  material (Fig.  4B, ZZ 
and HZ), providing evidence that  the nrichment of the  CFTR 
was not caused by a nonspecific binding of membrane proteins 
to  the beads. In  the case of detergent extracts of Beas and 
CF-T43  membranes, WGA-agarose did not bind a significant 
amount of the 180-kDa CFTR. 
The  CFTR is postulated to be a highly hydrophobic, integral 
membrane protein (2). To determine whether the 180-kDa, 
anti-CFTR antibody-reactive  band  represents an integral or 
a peripheral membrane protein, we subjected the isolated 
epithelial cell membranes to washes with a high ionic strength 
medium or with lithium diiodosalicylate, which dissociate 
peripheral  proteins from membranes  (30). These  treatments 
removed some of the low molecular mass anti-CFTR  anti- 
body-reactive proteins from T84 cell membranes and corre- 
spondingly enriched the membrane pellets with respect to  the 
180-kDa band. The distribution of a known integral mem- 
brane protein, the plasma membrane calcium ATPase 
(PMCA) was also determined. The 140-kDa PMCA parti- 
tioned in the same manner as the 180-kDa CFTR band, 
indicating that  the 180-kDa protein is also an integral mem- 
brane component. High salt  or lithium diiodosalicylate washes 
of airway epithelial cell membranes yielded identical results 
(data  not shown). 
In order to obtain  information as  to  the subcellular local- 
ization of the CFTR, crude membrane preparations from 
several cell lines were fractionated  on  a discontinuous sucrose 
density gradient, and  the resulting fractions were analyzed 
for the presence of a  variety of membrane markers. The cell 
surface of the  intact epithelial cells was labeled at  4 “C by 
enzymatic galactosidation, using the UDP-[‘HH]galactose gal- 
actosyltransferase system. This labeling results in the radio- 
active galactosidation of the cell surface glycoproteins that 
have glucose molecules at  the  end position (25). For specific 
plasma  membrane  markers,  antibodies to  the Na+,K+-ATPase 
and the plasma membrane calcium ATPase (PMCA) were 
used. Antibodies to  the sarcoendoplasmic reticulum calcium 
ATPase  (SERCA) were used to detect the presence of endo- 
plasmic reticulum, and  an antibody to  the inner mitochondrial 
membrane Complex I11 was used as a mitochondrial marker. 
The polyclonal anti-Na,K-ATPase antibody recognized both 
the (Y (about 100-kDa) and  the p (about 60-kDa) subunits of 
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the enzyme, and the monoclonal anti-PMCA antibody de- 
tected a 140-kDa protein, which is the monomer size of this 
ATPase. The anti-SERCA monoclonal antibody  reacted  with 
the 100-kDa calcium ATPase present in the endoplasmic 
reticulum, while the polyclonal antibody against the mito- 
chondrial  inner  membrane complex I11 detected five promi- 
nent  bands (two core proteins, two cytochromes, and iron- 
sulfur protein) in the range of about 45-24 kDa. 
Pilot experiments with various epithelial cells indicated 
that  the surface and intracellular organelle membranes  in  our 
crude membrane preparations could be effectively separated 
in sucrose step gradients at  sucrose concentrations between 
25 and 50%. The plasma membrane markers had the highest 
intensities at  the 35% sucrose shelf, while the endoplasmic 
reticulum marker was greatly enriched at  50% sucrose. The 
mitochondrial markers were found to be present in each 
density  gradient  fraction, but  the highest levels were found a t  
50% sucrose. The subcellular distribution of the various mark- 
ers is presented below as  part of Fig. 6. 
Fig. 5  demonstrates the distribution of the  anti-CFTR-C 
reactive bands of the Beas  (normal) and  the CF-T43 (AF 508 
homozygote) cell membranes in  the sucrose gradient fractions. 
For both membrane preparations, the 180-kDa CFTR  band 
had  the highest intensity at  the 35% sucrose shelf, where the 
plasma membrane markers are enriched (Fig. 6), while most 
of the lower molecular mass  antibody-reactive  proteins were 
concentrated  in the lower density  fractions. This  is  in good 
agreement with the fact that  these  proteins  are easily removed 
from the membranes by high salt  or lithium diiodosalicylate 
treatments. When  detected  with the  anti-R domain antibod- 
ies, the  CFTR showed the same localization in the sucrose 
fractions, and  the lower molecular mass bands were likewise 
enriched  in the lower density  fractions (data  not shown). 
Fig. 6 shows a  quantitative compilation of the  data obtained 
by densitometry of the CFTR, the PMCA, the SERCA, the 
Na’,K’-ATPase, and  the Complex I11 immunoreactive ma- 
terials, and by radioactivity measurements for the distribution 
of the [3H]galactose surface label, in  membrane  fractions from 
Beas  (normal) and CF-T43 (AF 508 CFTR) airway epithelial 
cells after sucrose density  gradient  centrifugation. Clearly, in 
both cell membranes, the 180-kDa CFTR co-localizes with 
the plasma membrane marker enzymes and with the peak of 
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FIG. 5. Distribution of the CFTR of Beas  (normal)  and CF- 
T43 (AF 508) airway  epithelial  cells  in  the  various  membrane 
fractions  separated  by  sucrose  density  gradient  centrifuga- 
tion. Membranes were fractionated on a sucrose step gradient, and 
aliquots of different fractions were precipitated with trichloroacetic 
acid and dissolved in SDS-PAGE disaggregation buffer as described 
under  “Experimental Procedures.” Samples were electrophoresed and 
immunoblotted, and  the immunostaining was visualized as described 
in  the legend  for  Fig. 1. Immunodetection was carried out with the 
anti-CFTR C terminus antibody. 10 pg of membrane protein was 
deposited in each well. Panel A, Beas cell membranes; panel B, CF- 
T43 cell membranes. Lanes 1, 0% sucrose supernatant fluid; lanes 2, 
membranes just above the 25% sucrose layer; lanes 3, membranes just 
above the 35% sucrose layer; lanes 4, membranes just above the 50% 
sucrose layer. 
A. BEAS Cells B. CF-T43 Cells 
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FIG. 6. Distribution of the  CFTR, [3H]galactose  surface  la- 
bel, and several membrane markers after sucrose density 
gradient  separation of membranes  from  normal  (Beas) (A, C) 
and AF 508 CF (CF-T43) (B,  D )  airway  epithelial cells. Mem- 
branes from [‘H]galactose-labeled cells were fractionated on a sucrose 
step gradient, and aliquots of different fractions were precipitated 
with trichloroacetic acid and dissolved in SDS-PAGE disaggregation 
buffer as described under  “Experimental Procedures.” Equal amounts 
of protein (10 pg) were deposited in each well. Samples were electro- 
phoresed and immunoblotted, and  the immunostaining was  visualized 
as described in the legend for Fig. 1. The intensity of the immuno- 
stained bands was quantitated by densitometry and computer inte- 
gration of the peak areas; tritium radioactivity in the fractions was 
measured by liquid scintillation counting. The peak values for each 
marker were arbitrarily taken as 100%. The  data represent means 
and S.D. values of three similar experiments; in the case of [3H] 
galactose, mean values of two experiments are shown. W, relative 
intensity of the 180-kDa band detected by anti-CFTR C terminus 
(K858) antibody; B, relative intensity of the 140-kDa band detected 
by the anti-PMCA (5F10) antibody; a, relative intensity of the 100- 
kDa band detected by the anti-SERCA  (IId8) antibody; 0, relative 
amount of [3H]galactose radioactivity; a, relative intensity of the 
Na’,K’-ATPase 100-kDa (a subunit) band detected by a polyclonal 
, relative intensity of the mitochondrial complex 111 
(combined values for cytochrome c1 and core proteins) detected by 
anti-complex 111 polyclonal antibody. 
the 3H activity. The CFTR is much less abundant in the 
lighter fractions and  at  the higher sucrose densities, where 
the endoplasmic reticulum and mitochondrial membranes are 
enriched. As shown in panels C and D, in contrast to the 
integral  plasma  membrane  markers, some [‘H]galactose label 
is also present  near to  the  top of the gradient, presumably 
reflecting the surface labeling of nonintegral membrane gly- 
coproteins or glycolipids. This  interpretation is supported by 
the  fact  that about 30% of the [’Hlgalactose label is removed 
from the membranes by extraction with 1 M KC1 (data not 
shown). Although not shown, in T84 cell membrane prepa- 
rations, the  CFTR  and  the different membrane markers ex- 
hibited the same distribution pattern  as demonstrated for the 
airway cells. 
Fig. 7 shows subcellular fractionation data for the  CFTR 
in  the sibling airway epithelial cell lines, HBE (normal)  and 
CFTl (AF 508 homozygote), as well as in the CFTl cells 
infected with CFTR cDNA-containing retroviral vector and 
thus expressing large amounts of the normal CFTR. Similar 
to  the results  obtained  with the Beas, CF-T43, and T84 cells, 
for all these cells the CFTR was enriched in the sucrose 
density fractions corresponding to the plasma membrane 
markers and  not  in  the heavier fractions enriched in endo- 
plasmic reticulum and mitochondrial membranes. 
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FIG. 7. Distribution of the CFTR after sucrose density gra- 
dient separation of membrane fractions of CFT1, HBE, and 
CFTl cells overexpressing the normal CFTR. Membranes were 
fractionated on a sucrose step gradient, and aliquots of different 
fractions were precipitated with trichloroacetic acid and dissolved in 
SDS-PAGE disaggregation buffer as described under “Experimental 
Procedures.” Samples were electrophoresed and immunoblotted, and 
the immunostaining by anti-CFTR C  terminus antibody (K858) was 
visualized as described in the legend for Fig. 1. Equal amounts of 
protein (10 pg) were deposited in each well. The intensity of the 
immunostained bands was quantitated by densitometry and com- 
puter-assisted integration of peak areas.  Data are from a  representa- 
tive experiment. , intensity of the 180-kDa CFTR  band  in CFTl 
cell membrane fractions; ., intensity of the 180-kDa CFTR  band  in 
HBE cell membrane fractions; H, intensity of the 180-kDa CFTR 
band in membrane fractions of CFTl cells infected with a retroviral 
vector containing the normal CFTR cDNA. 
DISCUSSION 
The cloning of the gene responsible for cystic fibrosis and 
the determination of the gene sequence (1-3) opened up many 
new avenues of approach to  the investigation of this severe 
genetic disease. In the present study, we have used this 
sequence information to prepare immunoreagents to be used 
in experiments to detect the  CF gene product and determine 
its biochemical features and cellular localization, with the 
future aim to purify it,  and eventually  ascertain its physiolog- 
ical function in  a  reconstituted system. 
Although not  elaborated upon under “Results,” several ob- 
stacles encountered in these  studies are worth  noting briefly. 
In order to avoid nonspecific reactions of the antisera on 
Western blots, the antibodies  had to be affinity-purified using 
the appropriate peptides immobilized on  a Sulfolink column. 
We also found that  standard SDS-PAGE and blotting tech- 
niques did not efficiently transfer  the high molecular mass 
integral membrane proteins,  rendering  a quantitative evalu- 
ation of the amounts of these proteins on Western blots 
impossible. However, the use of a high glycine, no  methanol 
transfer buffer (23) and high binding capacity  PVDF mem- 
branes, and  transfer from low percentage, preferably 6% or 
4-15% gradient acrylamide gels during  electroblotting, greatly 
improved the  transfer efficiency. Moreover, the visualization 
of the peroxidase-stained blots by enhanced chemiluminesce 
vastly improved the sensitivity of the technique, allowing the 
detection of CFTR  in whole cell or tissue samples, in crude 
membranes, and in sucrose density gradient fractions. By 
allowing different development times for the luminograms, a 
linear range for the protein concentrationband intensity 
ratio could be selected and  thus  the  intensities quantitatively 
assessed by computerized densitometry. 
The results  presented  demonstrate that polyclonal antibod- 
ies prepared  against sequences of the R domain and C  termi- 
nus of the  CFTR recognize a heterogeneous protein  band  in 
the region of 180 kDa. Consistent with relative CFTR mes- 
senger RNA levels (2,31),  the  amount of the 180-kDa protein 
was found to be much greater in  the T84 tumor cells than  in 
the airway epithelial cells. Moreover, carboxypeptidase Y 
digestion of the membranes eliminated the binding of the 
anti-C terminus antibody to the 180-kDa band, leaving its 
recognition by the  anti-R domain antibody unchanged. This 
result  indicates that  the  anti-R  and  anti-C antibody epitopes 
in  the 180-kDa protein  are in different locations and  that  the 
anti-C antibody reacted with an epitope located at the C 
terminus as expected from the  CFTR gene sequence. 
The most compelling evidence that  the approximately 180- 
kDa band is the CFTR came from the CFTR expression 
experiments. The  CFTR overexpressed in human epithelial 
cells and  in mouse fibroblasts via viral vectors, albeit with a 
somewhat different  appearance in  the different cell types, was 
identically recognized by both  types of the  anti-CFTR  anti- 
bodies at about 180 kDa. In  the airway cells, overexpression 
increased the intensity of the  sharp  CFTR bands and also 
produced a broad, fuzzy band similar to  that seen in the T84 
tumor cells (see Fig. 3). In  NIH  3T3 mouse fibroblasts, the 
CFTR overexpressed by the  human  CFTR cDNA showed a 
broad fuzzy band  in the 180-kDa region (Fig. 3B). When the 
CFTR was expressed in  insect Sf9 cells, similar to  an earlier 
report (16), a 140-kDa, probably un- or underglycosylated 
form of the protein, was detected by both the  anti-C  and  anti- 
R CFTR antibodies. This 140-kDa immunoreactive band, 
with relatively low intensity in the control cells, but increasing 
with overexpression of the  CFTR, was also observed in the 
human epithelial and in the NIH 3T3 cells. The smaller 
molecular mass proteins in various cells, recognized differ- 
ently by the different antibodies, are most probably not re- 
lated to  the  CFTR, inasmuch as  the  amounts of these  proteins 
do not change detectably when cells are overexpressing the 
CFTR. 
All the above findings strongly support the conclusion that 
our polyclonal antibodies recognize the CFTR and  that  the 
endogenous, mature CFTR  in human  epithelial cells has  an 
apparent molecular mass of about 180 kDa. Nevertheless, a 
molecular heterogeneity of the mature CFTR is suggested by 
the present experiments. In  the 165-185-kDa region of the 
immunoblots, multiple immunoreactive bands  can be resolved 
which, although similarly recognized by the different antibod- 
ies, are clearly different. N-Glycosidase treatment of the 
CFTR in  T84 cell membranes reduced the molecular mass of 
the major CFTR band from about 180 kDa to 140 kDa, 
equivalent to  the molecular mass of the underglycosylated 
CFTR  in Sf9 cells (Fig. 4A). However, certain  T84 cell CFTR 
bands  and most of the airway epithelial cell CFTR could not 
be enzymatically deglycosylated. Detergent-solubilized CFTR 
of T84 cell membranes was shown to be  specifically bound to 
wheat germ agglutinin agarose and then eluted with the 
leutin-specific sugar N-acetylglucosamine (Fig. 4B), while no 
such lectin agarose binding was found in the case of the 
airway epithelial cell CFTR.  These findings suggest a  different 
pattern of glycosylation and/or  other post-translational mod- 
ifications of this protein  in the different cells. The biosyn- 
thesis of heterogeneous forms and various glycosylation pat- 
terns of the multidrug  resistance  protein  (P-glycoprotein),  a 
protein apparently similar to  the CFTR, has already been 
described (32). An alternative  explanation for the differences 
observed here could be an incomplete solubilization of the 
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epithelial cell membranes in the detergents used and the 
formation of membrane protein clusters which may prevent 
glycosidase and/or specific lectin  interactions. Thus,  the  na- 
ture of the glycosylation and post-translational modification 
of the  CFTR  in  the various cell types requires further inves- 
tigation. 
Three  other  important biochemical features of the  CFTR 
are also apparent from these studies. First, treatment of 
isolated membranes by high salt concentrations and lithium 
diiodosalicylate, agents which remove loosely attached pro- 
teins (30), did not solubilize the CFTR,  indicating that it is 
an integral membrane  protein. Second, the fully mature, 180- 
kDa form of the  CFTR is present both  in normal and in AF 
508 mutant airway cells, indicating that  the Phe5OS deletion 
does not interfere in any major way with the normal biosyn- 
thesis of the endogenous CFTR.  Third,  in all of our experi- 
ments, it was observed that  the  CFTR is a minor membrane 
component, unrecognizable by Coomassie Blue protein stain- 
ing even in  the CFTR-overexpressing mammalian cells or in 
lectin-isolated  membrane glycoprotein fractions. 
A major question related to  the function of the  CFTR is its 
subcellular localization, as in CF a possible error in the 
cellular processing and transport of this protein has been 
suggested (17). Immunocytochemical techniques could be de- 
cisive in  this respect. However, such  studies have been made 
uncertain by the presence of lower molecular mass immuno- 
reactive proteins, possibly unrelated to the CFTR, in the 
epithelial cells. We therefore employed a biochemical ap- 
proach to establish the subcellular localization of the  CFTR. 
Because culturing of the airway epithelial cells in large quan- 
tities is time-consuming, laborious, and expensive, only sub- 
milligram quantities of membranes could be used for the 
fractionation studies. We therefore developed a relatively 
simple sucrose density step gradient  technique which proved 
to be useful in  differentiating between cell surface and  internal 
membranes in small samples of crude membranes. Moreover, 
the use of specific antibodies  against the relevant  membrane 
marker enzymes significantly improved the sensitivity of the 
detection over most conventional  marker enzyme assays. The 
significant  enrichment of the plasma membrane markers at 
the 35% sucrose shelf and  the  enrichment of the endoplasmic 
reticulum and mitochondrial  markers at higher sucrose den- 
sities indicates  a reasonably efficient separation of the differ- 
ent cellular membranes by this technique. 
The most important findings in  the subcellular localization 
experiments are  that  the  CFTR is a plasma membrane  protein 
and that it is localized in the plasma membranes of both 
normal and AF 508 homozygote airway epithelial cells. The 
experiments were carried out with two different  normal  (Beas 
and HBE) and two different AF 508 mutant (CF-T43 and 
CFT1) cell lines, and identical results were obtained in all 
cases (Figs. 6 and 7). A similar localization of the  CFTR was 
found for the airway cells expressing large amounts of the 
CFTR (Fig. 7) and for the  T84 cells as well. These results 
render it unlikely that  the major problem in the AF 508 CFTR 
cells is defective maturation  and/or  transport of the  mutant 
endogenous CFTR  to  the plasma membrane. Recent work  by 
Gregory et al. (33), involving expression of CFTR  mutants 
which lack glycosylation sites, clearly demonstrates that car- 
bohydrate  addition per se is not necessary for CFTR  to reach 
its  site of action or to generate CAMP-activated C1- channels. 
Thus, although in a heterologous expression system the  mat- 
uration of  AF 508 CFTR seems to be impaired (17), our 
results suggest that explanations for the CF pathogenesis 
other  than  the absence of the  CFTR  in  the plasma membrane 
are more likely to be correct. 
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